nicotine(redirected from Nicorette Patch)
Also found in: Dictionary, Encyclopedia.
Although nicotine is highly toxic, the amount inhaled while smoking tobacco is too small to cause death. The nicotine in tobacco can, however, cause indigestion and increase in blood pressure, and dull the appetite. It also acts as a vasoconstrictor. Researchers link smoking with heart disease, lung cancer, and other diseases.
nicotine nasal spray
nicotine transdermal system
Pharmacologic class: Cholinergic
Therapeutic class: Smoking deterrent
Pregnancy risk category C (gum), D (inhalation, nasal, transdermal)
Supplies nicotine during controlled withdrawal from cigarette smoking. Binds selectively to nicotinic-choliner-gic receptors in central and peripheral nervous systems, autonomic ganglia, adrenal medulla, and neuromuscular junction. At low doses, has a stimulating effect; at high doses, a reward effect.
Chewing gum: 2 mg, 4 mg
Inhalation: 42 cartridges/system, each containing 10 mg nicotine (delivers 4 mg)
Nasal spray: 10 mg/ml (0.5 mg/spray) in 10-ml bottles (100 doses)
Transdermal patch: 7 mg/day, 11 mg/day, 14 mg/day, 15 mg/day, 21 mg/day, 22 mg/day
Indications and dosages
➣ Adjunctive therapy (with behavior modification) for nicotine withdrawal Transdermal system-
Adults: 21 mg/day transdermally (Habitrol) for 4 to 8 weeks, then 14 mg/day for 2 to 4 weeks, then 7 mg/day for 2 to 4 weeks, for a total of 8 to 16 weeks; patient must wear system 24 hours/day. Or 21 mg/day transdermally (Nicoderm CQ) for 6 weeks, then 14 mg/day for 2 weeks, then 7 mg/day for 2 weeks, for a total of 10 weeks; patient must wear system 24 hours/day. Or 15 mg/day transdermally (one Nicotrol patch) for 6 weeks; patient must wear system 16 hours/day, removing it at bedtime.
Adults, adolescents, and children weighing less than 45 kg (100 lb) who smoke fewer than 10 cigarettes daily or have underlying cardiovascular disease: 14 mg/day transdermally (Habitrol) for 4 to 8 weeks, then 7 mg/day for 2 to 4 weeks, for a total of 6 to 8 weeks; patient must wear system 24 hours/day. Or 14 mg/day transdermally (Nicoderm CQ) for 6 weeks, then 7 mg/day for 2 weeks, for a total of 8 weeks; patient must wear system 24 hours/day. Nasal spray-
Adults: One spray intranasally in each nostril once or twice per hour, up to five times per hour or 40 times per day, for no longer than 6 months Inhalation-
Adults: For optimal response, at least six cartridges inhaled daily for first 3 to 6 weeks, to a maximum of 16 cartridges daily for up to 12 weeks. Patient self-titrates dosage to required nicotine level (usually 6 to 16 cartridges daily), followed by gradual withdrawal over 6 to 12 weeks.
Adults: Use as needed depending on smoking urge or chewing rate, or use on fixed schedule q 1 to 2 hours. Initial requirement may range from 18 to 48 mg/day, not to exceed 60 mg/day.
• Hypersensitivity to drug or its components or to menthol (inhaler only)
• Allergy to adhesive (transdermal forms only)
Use cautiously in:
• cardiovascular disease, hypertension, bronchospastic disease, diabetes mellitus, pheochromocytoma, peripheral vascular disease, hyperthyroidism, peptic ulcer disease, hepatic disease
• immediately after myocardial infarction, severe arrhythmia, or severe or worsening angina (use not recommended)
• skin disorders (transdermal form)
• dental disorders, esophagitis, pharyngitis, stomatitis (gum form)
• females of childbearing age
• pregnant or breastfeeding patients.
• children under age 18 (safety and efficacy not established).
• Apply patch when patient awakens and remove patch (as prescribed) at same time each day.
• Administer nasal spray regularly during first week, to help patient get used to irritant effects.
• With inhalation use, give at least six cartridges daily for first 3 to 6 weeks.
• Encourage patient to titrate dosage to level required, followed by gradual withdrawal.
CNS: headache, dizziness, drowsiness, poor concentration, nervousness, weakness, paresthesia, insomnia, abnormal dreams
CV: chest pain, hypertension, tachycardia, atrial fibrillation
EENT: sinusitis; pharyngitis (with gum); mouth and throat irritation (with inhaler); nasopharyngeal irritation, rhinitis, sneezing, watering eyes, eye irritation (with nasal spray)
GI: nausea, vomiting, diarrhea, constipation, abdominal pain, dry mouth, dyspepsia; increased salivation, sore mouth (with gum)
Musculoskeletal: joint pain, back pain, myalgia; jaw ache (with gum)
Respiratory: increased cough (with nasal spray or inhaler), bronchospasm
Skin: burning at patch site, erythema, pruritus, cutaneous hypersensitivity, rash, sweating (all with transdermal patch)
Other: abnormal taste, increased appetite (with gum), allergy, hiccups
Drug-drug. Acetaminophen, adrenergic antagonists (such as prazosin, labetalol), clozapine, furosemide, imipramine, oxazepam, pentazocine, propranolol and other beta-adrenergic blockers, theophylline: increased effects of these drugs
Bupropion: treatment-emergent hypertension
Insulin: decreased insulin requirement
Isoproterenol, phenylephrine: increased requirements for these drugs
Propoxyphene: decreased nicotine metabolism
Drug-food. Caffeine-containing foods and beverages: increased nicotine effects
Drug-behaviors. Cigarette smoking: increased nicotine metabolism and effects
• Assess for signs and symptoms of nicotine withdrawal (irritability, drowsiness, fatigue, headache).
Watch for bronchospasm and evidence of nicotine toxicity (nausea, vomiting, diarrhea, increased salivation, headache, dizziness, visual disturbances).
Caution patient against any type of smoking during therapy. Urge him to immediately report chest tightness or difficulty breathing.
• If patient uses gum, advise him to chew one piece whenever nicotine craving occurs. Instruct him to chew it slowly until he feels a tingling sensation, then store it between cheek and gum until tingling disappears.
• Instruct patient to apply transdermal patch to clean, dry skin of upper arm or torso when he awakens; to keep it in place when showering, bathing, or swimming; and to remove it at same time each day.
• If patient uses nasal spray, instruct him to tilt head back slightly when spraying. Remind him not to sniff, swallow, or inhale through nose.
• If patient uses inhalation form, teach him to puff continuously for 20 minutes and to use at least six cartridges daily for first 3 to 6 weeks.
• As appropriate, review all significant and life-threatening adverse reactions and interactions, especially those related to the drugs, foods, and behaviors mentioned above.
See also: tobacco.
Nicotine in inhaled tobacco smoke or in smokeless tobacco applied to buccal or nasal mucosa enters the circulation within seconds, causing an increase in heart rate, ventricular stroke volume, and myocardial oxygen consumption, as well as euphoria, heightened alertness, and a sense of relaxation. Nicotine use is powerfully addictive, readily leading to habituation, tolerance, and dependency. Withdrawal from nicotine causes restlessness, irritability, anxiety, difficulty concentrating, and craving for nicotine. Addiction to nicotine is the reason for most tobacco use and is thus directly responsible for the resulting morbidity and mortality.
nicotineSubstance abuse A colorless pyridine alkaloid in tobacco Routes Inhalation, skin absorption, ingestion, either accidental or suicidal Clinical Transient CNS stimulation followed by depression or paralysis, nausea, hypersalivation, abdominal pain, vomiting, diarrhea, cold sweats, headache, vertigo, confusion, incoordination, ↓ pulse rate, dyspnea with possible respiratory paralysis and intense vagal stimulation, which may cause cardiac arrest; death occurs 1-4 hrs after ingesting a fatal adult dose–> 60 mg Treatment Emesis, gastric lavage, atropine–Nicotiana tabacum stimulates cholinergic receptors. See Cigarette, Conicotine, Nicotine gum, Passive smoking, Smokeless tobacco, Smoking, Tobacco.
nicotineA highly poisonous alkaloid drug derived from the leaves of the tobacco plants Nicotiana tabacum and Nicotiana rustica . Large doses are fatal. Very small dose are obtained by inhaling the smoke from burning tobacco and this is done for the sake of the desired slight stimulant and mood-elevating effect and to alleviate nicotine withdrawal symptoms. Nicotine increases the heart rate and raises the blood pressure by narrowing small arteries. This effect can be dangerous. Nicotine, in the doses acquired by smokers, is comparatively harmless but the other constituents of tobacco smoke are responsible for an enormous burden of human disease. Nicotine is dispensed in the form of dummy cigarettes, skin patches and chewing gum so that people who wish to stop smoking may still, for a time, continue to enjoy the perceived advantages. The drug is also used as an insecticide.
nicotinean alkaloid derived from tobacco.
Patient discussion about nicotine
Q. nicotine patch does anyone know if you can use the patch for smokeless tobacco users,that dont smoke,and how well does it work,what are the side effects,i"ve been using smokeless tobacco for 24 years and would like to stop,tried going cold turkey,but it didnt work,my dr. said i should try the patch,but couldnt tell me if it would work or not.